Displaying 1 through 8 of 14 Next Page >>
|
| Pantec Biosolutions reports successful Phase I for delivery of FSH using P.L.E.A.S.E.® |
| Wednesday, February 24, 2010 |
Ruggell, Liechtenstein, 24 February 2010, Pantec Biosolutions AG announced today that it has achieved excellent results in a Phase I clinical trial of a FSH (follicle stimulating hormone) patch used in conjunction with the company’s novel P.L.E.A.S.E.® (Painless Laser Epidermal System) technology. Although smaller peptides and some proteins have previously been delivered transdermally, this is the first time a protein as large as 32 KDa has been successfully delivered in this way. |
| |
| Pantec Biosolutions is Granted SME Status in EU |
| Tuesday, December 15, 2009 |
Ruggell, Liechtenstein, 15 December 2009 - Pantec Biosolutions AG, announced today that the European Agency for the Evaluation of Medicinal Products (EMEA) has granted SME (Small and Medium Sized Enterprise) status to Pantec Biosolutions. |
| |
| Pantec Biosolutions Granted European Patent for P.L.E.A.S.E.® |
| Thursday, September 24, 2009 |
Ruggell, Liechtenstein, 24 September 2009 - Pantec Biosolutions AG, a privately-owned company developing innovative transdermal drug delivery products, announced today that it has been granted European Patent No. EP1874213, entitled 'LASER MICROPORATOR' by the European Patent Office. |
| |
| Pantec Biosolutions reports successful Phase I study into the delivery of triptorelin using P.L.E.A.S.E.® technology |
| Monday, April 20, 2009 |
| Ruggell, Liechtenstein, 20 April 2009, Pantec Biosolutions AG, a privately-owned company developing innovative transdermal drug delivery products, announced today that it has achieved excellent results in a Phase I clinical trial of a triptorelin patch used in conjunction with the company’s novel P.L.E.A.S.E.® (Painless Laser Epidermal System) |
| |
| Pantec Biosolutions Expands Scientific Advisory Board |
| Tuesday, February 17, 2009 |
| Ruggell, Liechtenstein, 17 February 2009, Pantec Biosolutions AG, a privately-owned company developing innovative technologies for transdermal drug delivery, today announced the expansion of its Scientific Advisory Board
|
| |
| Pantec Biosolutions Receives Marketing Clearance for P.L.E.A.S.E.® |
| Monday, December 1, 2008 |
| Ruggell, Liechtenstein, 01 December 2008 - Pantec Biosolutions AG,
|
| |
| Pantec Biosolutions receives ISO 13485 certification |
| Wednesday, September 24, 2008 |
| Ruggell, Liechtenstein, 24 September 2008, Pantec Biosolutions AG,
|
| |
| Pantec Biosolutions appoints new Board members |
| Thursday, May 15, 2008 |
| Ruggell, Liechtenstein, 15 May 2008, Pantec Biosolutions AG, a privately-owned company developing innovative technologies for transdermal drug delivery, today announces the appointment of Burkhard Feurstein and Michael Armbruester to the Board following their election at the annual shareholders meeting held on April 24, 2008.
Mr Feurstein is Director of |
| |
Next Page >>
|
